ID   GP220
AC   CVCL_S968
SY   IPA220; IPA-220; IPA220A
DR   BTO; BTO_0005466
DR   cancercelllines; CVCL_S968
DR   Cosmic; 887257
DR   Cosmic; 1460706
DR   Cosmic; 2036665
DR   GEO; GSM322179
DR   Progenetix; CVCL_S968
DR   Wikidata; Q54871631
RX   PubMed=8925130;
RX   PubMed=19563644;
CC   Characteristics: Established from a second passage nude mice xenograft.
CC   Doubling time: 22 hours (PubMed=8925130).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
RX   PubMed=8925130; DOI=10.1007/BF00193936;
RA   Gartner M.F.R.M., David L., Seruca R., Machado J.C., Sobrinho-Simoes M.;
RT   "Establishment and characterization of two cell lines derived from
RT   human diffuse gastric carcinomas xenografted in nude mice.";
RL   Virchows Arch. 428:91-98(1996).
//
RX   PubMed=19563644; DOI=10.1186/1755-8794-2-39; PMCID=PMC2709900;
RA   Buffart T.E., Tijssen M., El-Bchiri J., Duval A., van de Wiel M.A.,
RA   Ylstra B., Meijer G.A., Carvalho B.;
RT   "NMD inhibition fails to identify tumour suppressor genes in
RT   microsatellite stable gastric cancer cell lines.";
RL   BMC Med. Genomics 2:39.1-39.13(2009).
//